Neurology
News
COVID-19 linked to increased Alzheimer’s risk
“If this is another burden that’s increased by COVID, this is something we’re really going to have to prepare for.”
News
Vitamins or cocoa: Which preserves cognition?
“Even suboptimum levels of micronutrients and essential minerals can have significant consequences for brain health.”
From the Journals
Ketamine promising for rare condition linked to autism
Using parent-report instruments to assess treatment effects, ketamine was associated with “nominally significant” improvement in a variety of...
From the Journals
Parent training pays off for children with autism
A meta-analysis found benefits regardless of variables such as the child’s age and relationship to the caregiver.
Feature
Largest-ever study into the effects of cannabis on the brain
“The study wants to bring the two sides of the argument together and understand what’s really happening.”
From the Journals
Baseline neuromotor abnormalities persist in schizophrenia
Long-term follow-up data showed predictive value of dyskinesia and neurological soft signs for neuromotor dysfunction.
From the Journals
Subtle visual dysfunctions often precede early-stage psychosis
Unlike patients with nonpsychotic disorders, approximately 50%-60% of patients diagnosed with schizophrenia report visual dysfunctions.
Evidence-Based Reviews
Neuropsychiatric symptoms after stroke
Accurate identification is vital to optimizing recovery and quality of life.
Savvy Psychopharmacology
Drug-induced progressive multifocal leukoencephalopathy: Rare but serious
Mr. P, age 67, presents to the clinic with vision changes and memory loss following a fall in his home due to limb weakness.
From the Journals
Inhaled, systemic steroids linked to changes in brain structure
New research adds to the growing body of evidence suggesting that glucocorticoids have significant effects on the brain, which could explain their...
Conference Coverage
Sacubitril/valsartan shows cognitive safety in heart failure: PERSPECTIVE
Patients with heart failure on sacubitril/valsartan had no signal of cognitive decline, compared with controls in PERSPECTIVE, a prospective,...